Melanoma vaccines.
Melanoma vaccines offer new hope to patients with metastatic melanoma, although convincing survival advantages have yet to be reported. This review outlines the progress made in this exciting field of research and looks ahead to the future.
Elliott
Bruce
B
St George's Hospital Medical School, London SW17 0RE.
Dalgleish
Angus
A
D000951:Antigens, Neoplasm / Q000276:immunology; D019496:Cancer Vaccines / Q000276:immunology; D003713:Dendritic Cells / Q000276:immunology; D005544:Forecasting; D005732:Gangliosides / Q000276:immunology; D006360:Heat-Shock Proteins / Q000276:immunology; D006801:Humans; D008545:Melanoma / Q000276:immunology / Q000517:prevention & control*; D010455:Peptides / Q000276:immunology; D012878:Skin Neoplasms / Q000276:immunology / Q000517:prevention & control*; D019444:Vaccines, DNA / Q000276:immunology
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D005732:Gangliosides; D006360:Heat-Shock Proteins; D010455:Peptides; D019444:Vaccines, DNA